FDA Brief

Warning letters Biologics

FDA warning letter to

Microvascular Tissue, Inc.

Issued Dec 3, 2025Posted Dec 16, 2025Center for Biologics Evaluation and Research (CBER)

CGMP/Deviations/Biologics License Application (BLA). We haven't summarized this letter yet. Read it on fda.gov.